nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—ABCB1—esophageal cancer	0.556	1	CbGaD
Fentanyl—Alfentanil—ABCB1—esophageal cancer	0.000586	0.154	CrCbGaD
Fentanyl—Phenylbutazone—PTGS1—esophageal cancer	0.000576	0.151	CrCbGaD
Fentanyl—Bronchospasm—Capecitabine—esophageal cancer	0.000482	0.00138	CcSEcCtD
Fentanyl—Polyuria—Methotrexate—esophageal cancer	0.00048	0.00138	CcSEcCtD
Fentanyl—Immune system disorder—Cisplatin—esophageal cancer	0.00048	0.00138	CcSEcCtD
Fentanyl—Mediastinal disorder—Cisplatin—esophageal cancer	0.000479	0.00137	CcSEcCtD
Fentanyl—Sweating increased—Capecitabine—esophageal cancer	0.000477	0.00137	CcSEcCtD
Fentanyl—Angina pectoris—Capecitabine—esophageal cancer	0.000477	0.00137	CcSEcCtD
Fentanyl—Arrhythmia—Cisplatin—esophageal cancer	0.000475	0.00136	CcSEcCtD
Fentanyl—Bronchitis—Capecitabine—esophageal cancer	0.000471	0.00135	CcSEcCtD
Fentanyl—Alopecia—Cisplatin—esophageal cancer	0.00047	0.00135	CcSEcCtD
Fentanyl—Abdominal discomfort—Capecitabine—esophageal cancer	0.000469	0.00135	CcSEcCtD
Fentanyl—Pancytopenia—Capecitabine—esophageal cancer	0.000465	0.00133	CcSEcCtD
Fentanyl—Erythema—Cisplatin—esophageal cancer	0.000463	0.00133	CcSEcCtD
Fentanyl—Malnutrition—Cisplatin—esophageal cancer	0.000463	0.00133	CcSEcCtD
Fentanyl—Neutropenia—Capecitabine—esophageal cancer	0.000458	0.00131	CcSEcCtD
Fentanyl—Dysuria—Capecitabine—esophageal cancer	0.000458	0.00131	CcSEcCtD
Fentanyl—Flatulence—Cisplatin—esophageal cancer	0.000456	0.00131	CcSEcCtD
Fentanyl—Astemizole—ABCB1—esophageal cancer	0.000456	0.12	CrCbGaD
Fentanyl—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000455	0.0013	CcSEcCtD
Fentanyl—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000447	0.00128	CcSEcCtD
Fentanyl—Weight increased—Capecitabine—esophageal cancer	0.000446	0.00128	CcSEcCtD
Fentanyl—Visual disturbance—Methotrexate—esophageal cancer	0.000445	0.00128	CcSEcCtD
Fentanyl—Muscle spasms—Cisplatin—esophageal cancer	0.000445	0.00128	CcSEcCtD
Fentanyl—Weight decreased—Capecitabine—esophageal cancer	0.000443	0.00127	CcSEcCtD
Fentanyl—Hyperglycaemia—Capecitabine—esophageal cancer	0.000442	0.00127	CcSEcCtD
Fentanyl—Pneumonia—Capecitabine—esophageal cancer	0.000439	0.00126	CcSEcCtD
Fentanyl—Infestation—Capecitabine—esophageal cancer	0.000437	0.00125	CcSEcCtD
Fentanyl—Infestation NOS—Capecitabine—esophageal cancer	0.000437	0.00125	CcSEcCtD
Fentanyl—Vision blurred—Cisplatin—esophageal cancer	0.000436	0.00125	CcSEcCtD
Fentanyl—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000436	0.00125	CcSEcCtD
Fentanyl—Depression—Capecitabine—esophageal cancer	0.000435	0.00125	CcSEcCtD
Fentanyl—Tremor—Cisplatin—esophageal cancer	0.000434	0.00124	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000433	0.00124	CcSEcCtD
Fentanyl—Lethargy—Methotrexate—esophageal cancer	0.00043	0.00123	CcSEcCtD
Fentanyl—Ill-defined disorder—Cisplatin—esophageal cancer	0.00043	0.00123	CcSEcCtD
Fentanyl—Renal failure—Capecitabine—esophageal cancer	0.000429	0.00123	CcSEcCtD
Fentanyl—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000428	0.00123	CcSEcCtD
Fentanyl—Anaemia—Cisplatin—esophageal cancer	0.000428	0.00123	CcSEcCtD
Fentanyl—Jaundice—Capecitabine—esophageal cancer	0.000426	0.00122	CcSEcCtD
Fentanyl—Stomatitis—Capecitabine—esophageal cancer	0.000426	0.00122	CcSEcCtD
Fentanyl—Urinary tract infection—Capecitabine—esophageal cancer	0.000424	0.00122	CcSEcCtD
Fentanyl—Conjunctivitis—Capecitabine—esophageal cancer	0.000424	0.00122	CcSEcCtD
Fentanyl—Osteoarthritis—Methotrexate—esophageal cancer	0.000422	0.00121	CcSEcCtD
Fentanyl—Malaise—Cisplatin—esophageal cancer	0.000417	0.0012	CcSEcCtD
Fentanyl—Haematuria—Capecitabine—esophageal cancer	0.000416	0.00119	CcSEcCtD
Fentanyl—Leukopenia—Cisplatin—esophageal cancer	0.000414	0.00119	CcSEcCtD
Fentanyl—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000413	0.00118	CcSEcCtD
Fentanyl—Epistaxis—Capecitabine—esophageal cancer	0.000412	0.00118	CcSEcCtD
Fentanyl—Irritability—Methotrexate—esophageal cancer	0.000403	0.00115	CcSEcCtD
Fentanyl—Convulsion—Cisplatin—esophageal cancer	0.000401	0.00115	CcSEcCtD
Fentanyl—Mood swings—Methotrexate—esophageal cancer	0.0004	0.00115	CcSEcCtD
Fentanyl—Bradycardia—Capecitabine—esophageal cancer	0.000399	0.00114	CcSEcCtD
Fentanyl—Myalgia—Cisplatin—esophageal cancer	0.000394	0.00113	CcSEcCtD
Fentanyl—Haemoglobin—Capecitabine—esophageal cancer	0.000394	0.00113	CcSEcCtD
Fentanyl—Rhinitis—Capecitabine—esophageal cancer	0.000393	0.00113	CcSEcCtD
Fentanyl—Anxiety—Cisplatin—esophageal cancer	0.000393	0.00113	CcSEcCtD
Fentanyl—Haemorrhage—Capecitabine—esophageal cancer	0.000392	0.00112	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000391	0.00112	CcSEcCtD
Fentanyl—Hypoaesthesia—Capecitabine—esophageal cancer	0.00039	0.00112	CcSEcCtD
Fentanyl—Discomfort—Cisplatin—esophageal cancer	0.000389	0.00112	CcSEcCtD
Fentanyl—Pharyngitis—Capecitabine—esophageal cancer	0.000389	0.00111	CcSEcCtD
Fentanyl—Urinary tract disorder—Capecitabine—esophageal cancer	0.000387	0.00111	CcSEcCtD
Fentanyl—Oedema peripheral—Capecitabine—esophageal cancer	0.000386	0.00111	CcSEcCtD
Fentanyl—Connective tissue disorder—Capecitabine—esophageal cancer	0.000385	0.0011	CcSEcCtD
Fentanyl—Urethral disorder—Capecitabine—esophageal cancer	0.000384	0.0011	CcSEcCtD
Fentanyl—Breast disorder—Methotrexate—esophageal cancer	0.000381	0.00109	CcSEcCtD
Fentanyl—Oedema—Cisplatin—esophageal cancer	0.000378	0.00108	CcSEcCtD
Fentanyl—Anaphylactic shock—Cisplatin—esophageal cancer	0.000378	0.00108	CcSEcCtD
Fentanyl—Visual impairment—Capecitabine—esophageal cancer	0.000378	0.00108	CcSEcCtD
Fentanyl—Methadone—CYP19A1—esophageal cancer	0.000376	0.0988	CrCbGaD
Fentanyl—Infection—Cisplatin—esophageal cancer	0.000375	0.00108	CcSEcCtD
Fentanyl—Erythema multiforme—Capecitabine—esophageal cancer	0.000371	0.00106	CcSEcCtD
Fentanyl—Nervous system disorder—Cisplatin—esophageal cancer	0.000371	0.00106	CcSEcCtD
Fentanyl—Thrombocytopenia—Cisplatin—esophageal cancer	0.00037	0.00106	CcSEcCtD
Fentanyl—Tachycardia—Cisplatin—esophageal cancer	0.000369	0.00106	CcSEcCtD
Fentanyl—Skin disorder—Cisplatin—esophageal cancer	0.000367	0.00105	CcSEcCtD
Fentanyl—Eye disorder—Capecitabine—esophageal cancer	0.000366	0.00105	CcSEcCtD
Fentanyl—Tinnitus—Capecitabine—esophageal cancer	0.000365	0.00105	CcSEcCtD
Fentanyl—Hyperhidrosis—Cisplatin—esophageal cancer	0.000365	0.00105	CcSEcCtD
Fentanyl—Asthma—Methotrexate—esophageal cancer	0.000365	0.00104	CcSEcCtD
Fentanyl—Cardiac disorder—Capecitabine—esophageal cancer	0.000364	0.00104	CcSEcCtD
Fentanyl—Flushing—Capecitabine—esophageal cancer	0.000364	0.00104	CcSEcCtD
Fentanyl—Anorexia—Cisplatin—esophageal cancer	0.00036	0.00103	CcSEcCtD
Fentanyl—Angiopathy—Capecitabine—esophageal cancer	0.000356	0.00102	CcSEcCtD
Fentanyl—Immune system disorder—Capecitabine—esophageal cancer	0.000354	0.00101	CcSEcCtD
Fentanyl—Mediastinal disorder—Capecitabine—esophageal cancer	0.000353	0.00101	CcSEcCtD
Fentanyl—Hypotension—Cisplatin—esophageal cancer	0.000353	0.00101	CcSEcCtD
Fentanyl—Chills—Capecitabine—esophageal cancer	0.000352	0.00101	CcSEcCtD
Fentanyl—Arrhythmia—Capecitabine—esophageal cancer	0.00035	0.001	CcSEcCtD
Fentanyl—Abdominal discomfort—Methotrexate—esophageal cancer	0.00035	0.001	CcSEcCtD
Fentanyl—Alopecia—Capecitabine—esophageal cancer	0.000346	0.000993	CcSEcCtD
Fentanyl—Pancytopenia—Methotrexate—esophageal cancer	0.000346	0.000992	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000344	0.000986	CcSEcCtD
Fentanyl—Mental disorder—Capecitabine—esophageal cancer	0.000343	0.000984	CcSEcCtD
Fentanyl—Malnutrition—Capecitabine—esophageal cancer	0.000341	0.000978	CcSEcCtD
Fentanyl—Erythema—Capecitabine—esophageal cancer	0.000341	0.000978	CcSEcCtD
Fentanyl—Dysuria—Methotrexate—esophageal cancer	0.000341	0.000977	CcSEcCtD
Fentanyl—Neutropenia—Methotrexate—esophageal cancer	0.000341	0.000977	CcSEcCtD
Fentanyl—Paraesthesia—Cisplatin—esophageal cancer	0.000339	0.000972	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000339	0.000971	CcSEcCtD
Fentanyl—Dyspnoea—Cisplatin—esophageal cancer	0.000337	0.000965	CcSEcCtD
Fentanyl—Flatulence—Capecitabine—esophageal cancer	0.000336	0.000963	CcSEcCtD
Fentanyl—Erectile dysfunction—Methotrexate—esophageal cancer	0.000336	0.000962	CcSEcCtD
Fentanyl—Dysgeusia—Capecitabine—esophageal cancer	0.000334	0.000958	CcSEcCtD
Fentanyl—Back pain—Capecitabine—esophageal cancer	0.00033	0.000946	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS2—esophageal cancer	0.000329	0.0864	CrCbGaD
Fentanyl—Decreased appetite—Cisplatin—esophageal cancer	0.000328	0.000941	CcSEcCtD
Fentanyl—Muscle spasms—Capecitabine—esophageal cancer	0.000328	0.00094	CcSEcCtD
Fentanyl—Pneumonia—Methotrexate—esophageal cancer	0.000327	0.000937	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000326	0.000935	CcSEcCtD
Fentanyl—Infestation—Methotrexate—esophageal cancer	0.000325	0.000931	CcSEcCtD
Fentanyl—Drowsiness—Methotrexate—esophageal cancer	0.000325	0.000931	CcSEcCtD
Fentanyl—Infestation NOS—Methotrexate—esophageal cancer	0.000325	0.000931	CcSEcCtD
Fentanyl—Fexofenadine—ABCB1—esophageal cancer	0.000325	0.0852	CrCbGaD
Fentanyl—Depression—Methotrexate—esophageal cancer	0.000324	0.000929	CcSEcCtD
Fentanyl—Pain—Cisplatin—esophageal cancer	0.000323	0.000926	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000322	0.000923	CcSEcCtD
Fentanyl—Vision blurred—Capecitabine—esophageal cancer	0.000322	0.000922	CcSEcCtD
Fentanyl—Tremor—Capecitabine—esophageal cancer	0.00032	0.000916	CcSEcCtD
Fentanyl—Renal failure—Methotrexate—esophageal cancer	0.00032	0.000916	CcSEcCtD
Fentanyl—Stomatitis—Methotrexate—esophageal cancer	0.000317	0.000908	CcSEcCtD
Fentanyl—Ill-defined disorder—Capecitabine—esophageal cancer	0.000317	0.000907	CcSEcCtD
Fentanyl—Conjunctivitis—Methotrexate—esophageal cancer	0.000316	0.000905	CcSEcCtD
Fentanyl—Anaemia—Capecitabine—esophageal cancer	0.000315	0.000904	CcSEcCtD
Fentanyl—Diphenhydramine—PTGS1—esophageal cancer	0.000313	0.0823	CrCbGaD
Fentanyl—Sweating—Methotrexate—esophageal cancer	0.000312	0.000893	CcSEcCtD
Fentanyl—Feeling abnormal—Cisplatin—esophageal cancer	0.000311	0.000892	CcSEcCtD
Fentanyl—Haematuria—Methotrexate—esophageal cancer	0.00031	0.000888	CcSEcCtD
Fentanyl—Malaise—Capecitabine—esophageal cancer	0.000308	0.000882	CcSEcCtD
Fentanyl—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000307	0.000881	CcSEcCtD
Fentanyl—Epistaxis—Methotrexate—esophageal cancer	0.000307	0.000879	CcSEcCtD
Fentanyl—Vertigo—Capecitabine—esophageal cancer	0.000307	0.000878	CcSEcCtD
Fentanyl—Syncope—Capecitabine—esophageal cancer	0.000306	0.000877	CcSEcCtD
Fentanyl—Leukopenia—Capecitabine—esophageal cancer	0.000305	0.000875	CcSEcCtD
Fentanyl—Palpitations—Capecitabine—esophageal cancer	0.000302	0.000864	CcSEcCtD
Fentanyl—Loss of consciousness—Capecitabine—esophageal cancer	0.0003	0.000859	CcSEcCtD
Fentanyl—Body temperature increased—Cisplatin—esophageal cancer	0.000299	0.000856	CcSEcCtD
Fentanyl—Cough—Capecitabine—esophageal cancer	0.000298	0.000853	CcSEcCtD
Fentanyl—Hypertension—Capecitabine—esophageal cancer	0.000295	0.000844	CcSEcCtD
Fentanyl—Haemoglobin—Methotrexate—esophageal cancer	0.000293	0.00084	CcSEcCtD
Fentanyl—Haemorrhage—Methotrexate—esophageal cancer	0.000292	0.000836	CcSEcCtD
Fentanyl—Arthralgia—Capecitabine—esophageal cancer	0.000291	0.000832	CcSEcCtD
Fentanyl—Chest pain—Capecitabine—esophageal cancer	0.000291	0.000832	CcSEcCtD
Fentanyl—Myalgia—Capecitabine—esophageal cancer	0.000291	0.000832	CcSEcCtD
Fentanyl—Pharyngitis—Methotrexate—esophageal cancer	0.00029	0.00083	CcSEcCtD
Fentanyl—Anxiety—Capecitabine—esophageal cancer	0.00029	0.00083	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000289	0.000827	CcSEcCtD
Fentanyl—Urinary tract disorder—Methotrexate—esophageal cancer	0.000288	0.000826	CcSEcCtD
Fentanyl—Discomfort—Capecitabine—esophageal cancer	0.000287	0.000822	CcSEcCtD
Fentanyl—Urethral disorder—Methotrexate—esophageal cancer	0.000286	0.00082	CcSEcCtD
Fentanyl—Dry mouth—Capecitabine—esophageal cancer	0.000284	0.000814	CcSEcCtD
Fentanyl—Visual impairment—Methotrexate—esophageal cancer	0.000281	0.000806	CcSEcCtD
Fentanyl—Confusional state—Capecitabine—esophageal cancer	0.000281	0.000805	CcSEcCtD
Fentanyl—Oedema—Capecitabine—esophageal cancer	0.000278	0.000798	CcSEcCtD
Fentanyl—Hypersensitivity—Cisplatin—esophageal cancer	0.000278	0.000798	CcSEcCtD
Fentanyl—Infection—Capecitabine—esophageal cancer	0.000277	0.000793	CcSEcCtD
Fentanyl—Erythema multiforme—Methotrexate—esophageal cancer	0.000276	0.000791	CcSEcCtD
Fentanyl—Shock—Capecitabine—esophageal cancer	0.000274	0.000785	CcSEcCtD
Fentanyl—Nervous system disorder—Capecitabine—esophageal cancer	0.000273	0.000783	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—esophageal cancer	0.000273	0.000781	CcSEcCtD
Fentanyl—Thrombocytopenia—Capecitabine—esophageal cancer	0.000273	0.000781	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—esophageal cancer	0.000272	0.00078	CcSEcCtD
Fentanyl—Tachycardia—Capecitabine—esophageal cancer	0.000272	0.000779	CcSEcCtD
Fentanyl—Asthenia—Cisplatin—esophageal cancer	0.000271	0.000777	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—esophageal cancer	0.000271	0.000776	CcSEcCtD
Fentanyl—Skin disorder—Capecitabine—esophageal cancer	0.000271	0.000775	CcSEcCtD
Fentanyl—Hyperhidrosis—Capecitabine—esophageal cancer	0.000269	0.000771	CcSEcCtD
Fentanyl—Anorexia—Capecitabine—esophageal cancer	0.000265	0.000761	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—esophageal cancer	0.000265	0.000759	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—esophageal cancer	0.000264	0.000755	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—esophageal cancer	0.000263	0.000754	CcSEcCtD
Fentanyl—Chills—Methotrexate—esophageal cancer	0.000262	0.00075	CcSEcCtD
Fentanyl—Propafenone—ABCB1—esophageal cancer	0.000262	0.0687	CrCbGaD
Fentanyl—Hypotension—Capecitabine—esophageal cancer	0.00026	0.000746	CcSEcCtD
Fentanyl—Diarrhoea—Cisplatin—esophageal cancer	0.000258	0.000741	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—esophageal cancer	0.000258	0.000739	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—esophageal cancer	0.000256	0.000733	CcSEcCtD
Fentanyl—Erythema—Methotrexate—esophageal cancer	0.000254	0.000728	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—esophageal cancer	0.000254	0.000728	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000254	0.000727	CcSEcCtD
Fentanyl—Insomnia—Capecitabine—esophageal cancer	0.000252	0.000722	CcSEcCtD
Fentanyl—Paraesthesia—Capecitabine—esophageal cancer	0.00025	0.000717	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—esophageal cancer	0.000249	0.000713	CcSEcCtD
Fentanyl—Dyspnoea—Capecitabine—esophageal cancer	0.000248	0.000711	CcSEcCtD
Fentanyl—Back pain—Methotrexate—esophageal cancer	0.000246	0.000704	CcSEcCtD
Fentanyl—Dyspepsia—Capecitabine—esophageal cancer	0.000245	0.000702	CcSEcCtD
Fentanyl—Decreased appetite—Capecitabine—esophageal cancer	0.000242	0.000694	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00024	0.000689	CcSEcCtD
Fentanyl—Vomiting—Cisplatin—esophageal cancer	0.00024	0.000688	CcSEcCtD
Fentanyl—Fatigue—Capecitabine—esophageal cancer	0.00024	0.000688	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—esophageal cancer	0.000239	0.000686	CcSEcCtD
Fentanyl—Rash—Cisplatin—esophageal cancer	0.000238	0.000683	CcSEcCtD
Fentanyl—Pain—Capecitabine—esophageal cancer	0.000238	0.000682	CcSEcCtD
Fentanyl—Constipation—Capecitabine—esophageal cancer	0.000238	0.000682	CcSEcCtD
Fentanyl—Dermatitis—Cisplatin—esophageal cancer	0.000238	0.000682	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—esophageal cancer	0.000236	0.000675	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—esophageal cancer	0.000235	0.000673	CcSEcCtD
Fentanyl—Bepridil—ABCB1—esophageal cancer	0.000233	0.0612	CrCbGaD
Fentanyl—Feeling abnormal—Capecitabine—esophageal cancer	0.000229	0.000658	CcSEcCtD
Fentanyl—Malaise—Methotrexate—esophageal cancer	0.000229	0.000656	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—esophageal cancer	0.000228	0.000654	CcSEcCtD
Fentanyl—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000228	0.000653	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—esophageal cancer	0.000227	0.000652	CcSEcCtD
Fentanyl—Nausea—Cisplatin—esophageal cancer	0.000224	0.000643	CcSEcCtD
Fentanyl—Cough—Methotrexate—esophageal cancer	0.000222	0.000635	CcSEcCtD
Fentanyl—Urticaria—Capecitabine—esophageal cancer	0.000221	0.000634	CcSEcCtD
Fentanyl—Abdominal pain—Capecitabine—esophageal cancer	0.00022	0.000631	CcSEcCtD
Fentanyl—Body temperature increased—Capecitabine—esophageal cancer	0.00022	0.000631	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—esophageal cancer	0.00022	0.000631	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—esophageal cancer	0.000216	0.00062	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—esophageal cancer	0.000216	0.00062	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—esophageal cancer	0.000216	0.00062	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000215	0.000615	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—esophageal cancer	0.000214	0.000612	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—esophageal cancer	0.000209	0.000599	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—esophageal cancer	0.000207	0.000594	CcSEcCtD
Fentanyl—Loperamide—ABCB1—esophageal cancer	0.000207	0.0542	CrCbGaD
Fentanyl—Infection—Methotrexate—esophageal cancer	0.000206	0.00059	CcSEcCtD
Fentanyl—Hypersensitivity—Capecitabine—esophageal cancer	0.000205	0.000588	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—esophageal cancer	0.000203	0.000583	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—esophageal cancer	0.000203	0.000582	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—esophageal cancer	0.000201	0.000577	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—esophageal cancer	0.0002	0.000574	CcSEcCtD
Fentanyl—Asthenia—Capecitabine—esophageal cancer	0.0002	0.000573	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—esophageal cancer	0.000198	0.000566	CcSEcCtD
Fentanyl—Pruritus—Capecitabine—esophageal cancer	0.000197	0.000565	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—esophageal cancer	0.000194	0.000555	CcSEcCtD
Fentanyl—Diarrhoea—Capecitabine—esophageal cancer	0.000191	0.000546	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000189	0.000541	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—esophageal cancer	0.000188	0.000537	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—esophageal cancer	0.000186	0.000533	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—esophageal cancer	0.000185	0.00053	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—esophageal cancer	0.000184	0.000528	CcSEcCtD
Fentanyl—Dizziness—Capecitabine—esophageal cancer	0.000184	0.000528	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—esophageal cancer	0.000182	0.000523	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—esophageal cancer	0.00018	0.000516	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000179	0.000513	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—esophageal cancer	0.000179	0.000512	CcSEcCtD
Fentanyl—Pain—Methotrexate—esophageal cancer	0.000177	0.000508	CcSEcCtD
Fentanyl—Vomiting—Capecitabine—esophageal cancer	0.000177	0.000507	CcSEcCtD
Fentanyl—Rash—Capecitabine—esophageal cancer	0.000176	0.000503	CcSEcCtD
Fentanyl—Dermatitis—Capecitabine—esophageal cancer	0.000175	0.000503	CcSEcCtD
Fentanyl—Headache—Capecitabine—esophageal cancer	0.000174	0.0005	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—esophageal cancer	0.000171	0.00049	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00017	0.000486	CcSEcCtD
Fentanyl—Nausea—Capecitabine—esophageal cancer	0.000165	0.000474	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—esophageal cancer	0.000165	0.000472	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—esophageal cancer	0.000164	0.00047	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—esophageal cancer	0.000164	0.00047	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—esophageal cancer	0.000153	0.000438	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—esophageal cancer	0.000149	0.000426	CcSEcCtD
Fentanyl—Methadone—ABCB1—esophageal cancer	0.000147	0.0386	CrCbGaD
Fentanyl—Pruritus—Methotrexate—esophageal cancer	0.000147	0.00042	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—esophageal cancer	0.000142	0.000406	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—esophageal cancer	0.000137	0.000393	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—esophageal cancer	0.000132	0.000378	CcSEcCtD
Fentanyl—Rash—Methotrexate—esophageal cancer	0.000131	0.000375	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—esophageal cancer	0.000131	0.000374	CcSEcCtD
Fentanyl—Headache—Methotrexate—esophageal cancer	0.00013	0.000372	CcSEcCtD
Fentanyl—Nausea—Methotrexate—esophageal cancer	0.000123	0.000353	CcSEcCtD
Fentanyl—OPRM1—Signaling by GPCR—CXCL2—esophageal cancer	7.02e-05	0.000766	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—SST—esophageal cancer	6.99e-05	0.000762	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GHRL—esophageal cancer	6.81e-05	0.000743	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	6.76e-05	0.000737	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HIST1H2BM—esophageal cancer	6.74e-05	0.000735	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PDE4D—esophageal cancer	6.68e-05	0.000728	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	6.67e-05	0.000727	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CSNK1A1—esophageal cancer	6.59e-05	0.000719	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ELMO1—esophageal cancer	6.55e-05	0.000714	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ANXA1—esophageal cancer	6.53e-05	0.000712	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ADH1B—esophageal cancer	6.44e-05	0.000702	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKAP13—esophageal cancer	6.4e-05	0.000698	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	6.35e-05	0.000693	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GNG7—esophageal cancer	6.35e-05	0.000693	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—SST—esophageal cancer	6.35e-05	0.000692	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	6.27e-05	0.000683	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CA1—esophageal cancer	6.24e-05	0.000681	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC10A2—esophageal cancer	6.24e-05	0.000681	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.22e-05	0.000678	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GHRL—esophageal cancer	6.19e-05	0.000675	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PFN1—esophageal cancer	6.16e-05	0.000672	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TYMP—esophageal cancer	6.16e-05	0.000671	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP26A1—esophageal cancer	5.99e-05	0.000653	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—XIAP—esophageal cancer	5.95e-05	0.000649	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HIST1H2BM—esophageal cancer	5.91e-05	0.000644	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PDE4D—esophageal cancer	5.86e-05	0.000639	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALOX15—esophageal cancer	5.84e-05	0.000636	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CA2—esophageal cancer	5.71e-05	0.000623	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.64e-05	0.000615	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CTNNA1—esophageal cancer	5.63e-05	0.000614	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL2—esophageal cancer	5.6e-05	0.00061	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	5.58e-05	0.000608	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNG7—esophageal cancer	5.57e-05	0.000607	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTO1—esophageal cancer	5.57e-05	0.000607	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TPI1—esophageal cancer	5.57e-05	0.000607	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.55e-05	0.000605	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC52A3—esophageal cancer	5.54e-05	0.000604	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—BLVRB—esophageal cancer	5.54e-05	0.000604	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ELMO1—esophageal cancer	5.54e-05	0.000604	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKAP13—esophageal cancer	5.41e-05	0.00059	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALDOB—esophageal cancer	5.34e-05	0.000582	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PLCE1—esophageal cancer	5.31e-05	0.000579	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ADH7—esophageal cancer	5.31e-05	0.000579	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PSME1—esophageal cancer	5.23e-05	0.00057	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PSME2—esophageal cancer	5.23e-05	0.00057	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—XIAP—esophageal cancer	5.22e-05	0.000569	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ANXA1—esophageal cancer	5.2e-05	0.000567	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GAPDH—esophageal cancer	5.14e-05	0.00056	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CRABP1—esophageal cancer	5.09e-05	0.000555	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SST—esophageal cancer	5.06e-05	0.000552	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	4.99e-05	0.000545	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PDE4D—esophageal cancer	4.95e-05	0.00054	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNA1—esophageal cancer	4.94e-05	0.000538	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GHRL—esophageal cancer	4.93e-05	0.000538	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH3—esophageal cancer	4.93e-05	0.000538	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL2—esophageal cancer	4.91e-05	0.000535	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FBXW7—esophageal cancer	4.85e-05	0.000529	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GNG7—esophageal cancer	4.84e-05	0.000528	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.79e-05	0.000522	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CA1—esophageal cancer	4.71e-05	0.000514	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC10A2—esophageal cancer	4.71e-05	0.000514	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNG7—esophageal cancer	4.71e-05	0.000513	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ADH1B—esophageal cancer	4.66e-05	0.000508	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.65e-05	0.000507	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PSME2—esophageal cancer	4.58e-05	0.0005	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PSME1—esophageal cancer	4.58e-05	0.0005	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ANXA1—esophageal cancer	4.56e-05	0.000497	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.55e-05	0.000496	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALDH2—esophageal cancer	4.54e-05	0.000495	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TYMP—esophageal cancer	4.45e-05	0.000485	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SST—esophageal cancer	4.44e-05	0.000484	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH2—esophageal cancer	4.42e-05	0.000482	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—XIAP—esophageal cancer	4.41e-05	0.000481	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP26A1—esophageal cancer	4.33e-05	0.000472	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GHRL—esophageal cancer	4.33e-05	0.000472	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH3—esophageal cancer	4.33e-05	0.000472	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTT1—esophageal cancer	4.32e-05	0.000471	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CA2—esophageal cancer	4.31e-05	0.00047	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP2A6—esophageal cancer	4.27e-05	0.000465	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	4.26e-05	0.000464	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALOX15—esophageal cancer	4.22e-05	0.00046	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	4.17e-05	0.000455	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	4.15e-05	0.000452	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.11e-05	0.000448	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS1—esophageal cancer	4.04e-05	0.000441	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ENO1—esophageal cancer	4.04e-05	0.000441	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTO1—esophageal cancer	4.02e-05	0.000439	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TPI1—esophageal cancer	4.02e-05	0.000439	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PLCE1—esophageal cancer	4.01e-05	0.000437	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADH7—esophageal cancer	4.01e-05	0.000437	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PSME2—esophageal cancer	3.99e-05	0.000435	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PSME1—esophageal cancer	3.99e-05	0.000435	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.97e-05	0.000433	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	3.93e-05	0.000428	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	3.88e-05	0.000423	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PSME1—esophageal cancer	3.87e-05	0.000422	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PSME2—esophageal cancer	3.87e-05	0.000422	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALDOB—esophageal cancer	3.86e-05	0.000421	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	3.86e-05	0.00042	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.78e-05	0.000412	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SST—esophageal cancer	3.75e-05	0.000409	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	3.72e-05	0.000405	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GAPDH—esophageal cancer	3.71e-05	0.000405	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CRABP1—esophageal cancer	3.68e-05	0.000401	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GHRL—esophageal cancer	3.66e-05	0.000399	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	3.66e-05	0.000399	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	3.6e-05	0.000392	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADH1B—esophageal cancer	3.51e-05	0.000383	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNG7—esophageal cancer	3.5e-05	0.000382	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	3.44e-05	0.000375	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP1B1—esophageal cancer	3.44e-05	0.000375	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.44e-05	0.000375	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.41e-05	0.000372	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.41e-05	0.000372	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TYMP—esophageal cancer	3.36e-05	0.000366	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.29e-05	0.000359	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALDH2—esophageal cancer	3.28e-05	0.000358	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	3.28e-05	0.000357	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.27e-05	0.000356	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	3.26e-05	0.000355	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP19A1—esophageal cancer	3.23e-05	0.000353	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.22e-05	0.000351	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALOX15—esophageal cancer	3.18e-05	0.000347	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTT1—esophageal cancer	3.12e-05	0.00034	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP2A6—esophageal cancer	3.08e-05	0.000336	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	3.04e-05	0.000331	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TPI1—esophageal cancer	3.04e-05	0.000331	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTO1—esophageal cancer	3.04e-05	0.000331	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HMOX1—esophageal cancer	2.95e-05	0.000322	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ENO1—esophageal cancer	2.92e-05	0.000319	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.92e-05	0.000319	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALDOB—esophageal cancer	2.91e-05	0.000317	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	2.91e-05	0.000317	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KDR—esophageal cancer	2.91e-05	0.000317	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.9e-05	0.000317	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CA1—esophageal cancer	2.9e-05	0.000317	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PSME2—esophageal cancer	2.88e-05	0.000314	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PSME1—esophageal cancer	2.88e-05	0.000314	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ABCB1—esophageal cancer	2.83e-05	0.000309	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GAPDH—esophageal cancer	2.8e-05	0.000306	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.8e-05	0.000305	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CRABP1—esophageal cancer	2.78e-05	0.000303	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	2.75e-05	0.0003	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	2.74e-05	0.000299	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.71e-05	0.000295	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	2.67e-05	0.000291	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CA2—esophageal cancer	2.66e-05	0.000289	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNG7—esophageal cancer	2.64e-05	0.000288	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KDR—esophageal cancer	2.55e-05	0.000278	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.49e-05	0.000271	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	2.48e-05	0.000271	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALDH2—esophageal cancer	2.48e-05	0.00027	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADH7—esophageal cancer	2.47e-05	0.000269	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.47e-05	0.000269	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	2.44e-05	0.000266	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	2.4e-05	0.000262	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTT1—esophageal cancer	2.35e-05	0.000257	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.34e-05	0.000255	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.33e-05	0.000254	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.33e-05	0.000254	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	2.25e-05	0.000246	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—esophageal cancer	2.22e-05	0.000242	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ENO1—esophageal cancer	2.21e-05	0.000241	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS1—esophageal cancer	2.21e-05	0.000241	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.2e-05	0.00024	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	2.18e-05	0.000237	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSME2—esophageal cancer	2.17e-05	0.000237	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSME1—esophageal cancer	2.17e-05	0.000237	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.16e-05	0.000236	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—esophageal cancer	2.15e-05	0.000235	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	2.14e-05	0.000233	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.13e-05	0.000233	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	2.12e-05	0.000231	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	2.08e-05	0.000227	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TYMP—esophageal cancer	2.07e-05	0.000226	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.05e-05	0.000223	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.04e-05	0.000223	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	2.03e-05	0.000221	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.01e-05	0.000219	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.96e-05	0.000214	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—esophageal cancer	1.95e-05	0.000213	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.89e-05	0.000206	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.88e-05	0.000205	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.87e-05	0.000204	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TPI1—esophageal cancer	1.87e-05	0.000204	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	1.86e-05	0.000202	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	1.84e-05	0.000201	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—esophageal cancer	1.84e-05	0.0002	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	1.82e-05	0.000199	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	1.81e-05	0.000197	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.79e-05	0.000196	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	1.78e-05	0.000194	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.76e-05	0.000192	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.73e-05	0.000188	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.73e-05	0.000188	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.71e-05	0.000187	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—esophageal cancer	1.69e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EP300—esophageal cancer	1.69e-05	0.000184	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—esophageal cancer	1.65e-05	0.00018	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNG7—esophageal cancer	1.63e-05	0.000177	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—esophageal cancer	1.61e-05	0.000176	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—esophageal cancer	1.61e-05	0.000175	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.57e-05	0.000171	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	1.56e-05	0.00017	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—esophageal cancer	1.55e-05	0.000169	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	1.54e-05	0.000168	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.53e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EP300—esophageal cancer	1.48e-05	0.000162	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—esophageal cancer	1.47e-05	0.000161	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.45e-05	0.000158	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—esophageal cancer	1.44e-05	0.000157	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.43e-05	0.000156	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.37e-05	0.000149	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—esophageal cancer	1.36e-05	0.000148	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ENO1—esophageal cancer	1.36e-05	0.000148	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.36e-05	0.000148	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSME1—esophageal cancer	1.34e-05	0.000146	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSME2—esophageal cancer	1.34e-05	0.000146	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	1.32e-05	0.000144	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—esophageal cancer	1.29e-05	0.000141	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—EP300—esophageal cancer	1.29e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—esophageal cancer	1.26e-05	0.000138	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EP300—esophageal cancer	1.25e-05	0.000137	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	1.25e-05	0.000136	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—esophageal cancer	1.23e-05	0.000134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—esophageal cancer	1.21e-05	0.000132	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.16e-05	0.000126	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.12e-05	0.000122	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	1.1e-05	0.00012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—esophageal cancer	1.09e-05	0.000119	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.09e-05	0.000118	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—esophageal cancer	1.07e-05	0.000116	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—esophageal cancer	1.06e-05	0.000116	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CREBBP—esophageal cancer	1.03e-05	0.000113	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—esophageal cancer	9.92e-06	0.000108	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—esophageal cancer	9.54e-06	0.000104	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCB1—esophageal cancer	9.52e-06	0.000104	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—EP300—esophageal cancer	9.32e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	9.27e-06	0.000101	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—esophageal cancer	9.24e-06	0.000101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—esophageal cancer	8.97e-06	9.78e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—esophageal cancer	8.45e-06	9.22e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—EP300—esophageal cancer	7.03e-06	7.67e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—esophageal cancer	6.89e-06	7.52e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.36e-06	6.93e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—esophageal cancer	5.7e-06	6.21e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.21e-06	5.68e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.2e-06	5.67e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—EP300—esophageal cancer	4.33e-06	4.72e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.2e-06	3.49e-05	CbGpPWpGaD
